BACE1 and Alzheimer disease: These events can drive AD pathophysiology, as SORL1 has a neuroprotective property by binding to apolipoprotein E (APOE), which interacts with Aβ, reducing APP oligomerization in the BACE1 amyloid pathway [109,142,146,147,148].